Interaction of synthetic peptide octarphin (TPLVTLFK) with human blood lymphocytes

Journal of Peptide Science

Volumn 19, Issue 8, 2013, Pages 499-503

  Nekrasova, Yuliia N ^a   Navolotskaya, Elena V ^a  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

Author keywords

endorphin; Lymphocyte; Peptide; Receptor

Indexed keywords

ALPHA ENDORPHIN; BETA ENDORPHIN; GAMMA ENDORPHIN; LEUCINE ENKEPHALIN; METENKEPHALIN; NALOXONE; OCTARPHIN; OPIATE RECEPTOR; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; B LYMPHOCYTE; BINDING AFFINITY; BINDING SITE; CELL INTERACTION; HUMAN; HUMAN CELL; INCUBATION TIME; PRIORITY JOURNAL; PROTEIN INTERACTION; T LYMPHOCYTE;

Β-ENDORPHIN; LYMPHOCYTE; PEPTIDE; RECEPTOR;

AMINO ACID SEQUENCE; B-LYMPHOCYTES; BETA-ENDORPHIN; BINDING SITES; BINDING, COMPETITIVE; CELLS, CULTURED; HUMANS; INHIBITORY CONCENTRATION 50; NALOXONE; NARCOTIC ANTAGONISTS; OLIGOPEPTIDES; PROTEIN BINDING; RECEPTORS, OPIOID; T-LYMPHOCYTES;

EID: 84880331682     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.2527     Document Type: Article

References (39)

1. Li CH. β-Endorphin. Cell 1982; 31: 504-505.
2. Hazum E, Chang KJ, Cuatrecasas P. Specific non-opiate receptors for β-endorphin. Science 1979; 205: 1033-1035.
3. Navolotskaya EV, Kovalitskaya YA, Zolotarev YA, Sadovnikov VB. Binding of synthetic fragments of β-endorphin to non-opioid β-endorphin receptor. J. Pept. Sci. 2008; 14: 1121-1128.
4. Kovalitskaya YA, Nekrasova YN, Sadovnokov VB, Navolotskaya EV. Immunostimulating effect of synthetic peptide octarphin corresponding to β-endorphin fragment12-19. Biochemistry (Moscow) 2011; 76: 596-604.
5. Nekrasova YN, Sadovnikov VB, Zolotarev YA, Navolotskaya EV. Binding of synthetic peptide TPLVTLFK to non-opioid beta-endorphin receptor on rat brain membranes. J. Pept. Sci. 2010; 16: 263-268.
6. Nekrasova YN, Zolotarev YA, Navolotskaya EV. Interaction of synthetic peptide octarphin with rat myocardium membranes. Biochemistry (Moscow) 2011; 76: 1337-1341.
7. Nekrasova YN, Zolotarev YA, Navolotskaya EV. Detection of non-opioid β-endorphin receptor in the rat myocardium. J. Pept. Sci. 2012; 18: 83-87.
8. Nekrasova YN, Zolotarev YA, Navolotskaya EV. Synthetic peptide TPLVTLFK (octarphin) reduces the corticosterone production by rat adrenal cortex through non-opioid β-endorphin receptor. J. Pept. Sci 2012; 18: 495-499.
9. Schnolzer M, Alewood P, Jones A, Alewood D, Kent SB. In situ neutralization in Boc-chemistry solid phase peptide synthesis. Rapid, high yield assembly of difficult sequences. Int. J. Peptide Protein Res 1992; 40: 180-193.
10. Zolotarev YA, Dadayan AK, Bocharov EV, Borisov YA, Vaskovsky BV, Dorokhova EM, Myasoedov NF. New development in the tritium labeling of peptides and proteins using solid catalytic isotopic exchange with spillover-tritium. Amino Acids 2003; 24: 325-333.
11. Boyum A, Berg T, Blomhoff R. Fractionation of Mammalian Cells. Oxford: IRL Press at Oxford University Press, 1983; 147-171.
12. Patel D, Rubbi CP, Rickwood D. Separation of T and B lymphocytes from human peripheral blood mononuclear cells using density perturbation methods. Clin. Chim. Acta 1995; 240: 187-193.
13. Pennock BE. A calculator for finding binding parameters from a Scatchard plot. Anal. Biochem. 1973; 56: 306-309.
14. 50) of an enzymatic reaction. Biochem. Pharmacol. 1973; 22: 3099-3108.
15. Giordano A, Nock B, Cicero J. Antagonist-induced up-regulation of the putative epsilon opioid receptor in rat brain: comparison with kappa, mu and delta opioid receptors. J. Pharmacol. Exp. Ther. 1990; 255: 536-540.
16. Zagon IS, Goodman SR, McLaughlin PJ. Zeta (ζ), the opioid growth factor receptor: identification and characterization of binding subunits. Brain Res. 1993; 605: 50-56.
17. Narita M, Tseng LF. Evidence for the existence of the β-endorphin-sensitive "ε-opioid receptor" in the brain: the mechanisms of ε-mediated antinociception. Jpn. J. Pharmacol. 1998; 76: 233-253.
18. Stefano GB, Goumon Y, Casares F, Cadet P, Fricchione GL, Rialas C, Peter D, Sonetti D, Guarna M, Welters ID, Bianchi E. Endogenous morphine. Trends Neurosci. 2000; 23: 436-442.
19. Grevel JYuV, Sadee W. Characterization of a labile naloxone binding site (lambda site) in rat brain. J. Neurochem. 1985; 44: 1647-1656.
20. Mehrishi JN, Mills IH. Opiate receptors on lymphocytes and platelets in man. Clin. Immunol. Immunopathol. 1983; 27: 240-249.
21. Carr DJJ, Kim C-H, deCosta B. Evidence for a δ-class opioid receptor on cells of the immune system. Cell. Immunol. 1988; 116: 44-51.
22. Carr DJJ. The role of endogenous opioids and their receptors in the immune system. Proc. Soc. Exp. Biol. Med. 1991; 198: 710-720.
23. Schweigerer L, Schmidt W, Teschemacher H, Gramsch C. β-Endorphin: surface binding and internalization in thymoma cells. Proc. Natl. Acad. Sci. USA 1985; 82: 5751-5755.
24. Schweiigerer L, Schmidt W, Teschermacher H, Wilhelm S. β-Endorphin: interaction with specific non-opioid binding sites on EL-4 thymoma cells. Neuropeptides 1985; 6: 445-452.
25. Shahabi NA, Peterson PK, Sharp B. β-Endorphin binding to naloxone-insensitive sites on a human mononuclear cell line (U937): effects of cations and guanosine triphosphate. Endocrinology 1990; 126: 3006-3015.
26. Shahabi NA, Linner KM, Sharp BM. Murine splenocytes express a naloxone-insensitive binding site for β-endorphin. Endocrinology 1990; 126: 1442-1448.
27. Howard AD, de La Baume S, Gioammini TL. Covalent labeling of opioid receptors with radio-iodinated human β-endorphin. Identification of binding site subunit. J. Biol. Chem. 1985; 260: 10833-10839.
28. Akil H, Young E, Watson SJ, Coy DH. Opiate binding properties of naturally occurring N- and C-terminus modified β-endorphins. Peptides 1981; 2: 289-292.
29. McCain HW, Lamster IB, Bozzone JM, Grbic JT. β-Endorphin modulates human immune activity via non-opiate receptor mechanisms. Life Sci. 1982; 31: 1619-1624.
30. 1-31 on murine splenocyte proliferation via a naloxone-resistant receptor. Biochem. Biophys. Res. Commun. 1991; 175: 936-942.
31. Hemmick LM, Bidlack JM. β-Endorphin stimulates rat T lymphocyte proliferation. J. Neuroimmunol. 1990; 29: 239-248.
32. Gilmar SC, Schwartz JM, Milner RJ, Bloom FE, Feldman JD. β-Endorphin enhances lymphocytes proliferative responses. Proc. Natl. Acad. Sci. USA 1982; 79: 4226-4230.
33. Gilmore W, Moloney M, Berinstein T. The enhancement of polyclonal T cell proliferation by β-endorphin. Brain Res. Bull. 1990; 24: 687-692.
34. Van Den Bergh P, Rozing J, Nagelkerken L. Two opposing modes of action of β-endorphin on lymphocyte function. Immunology 1991; 72: 537-543.
35. Van Den Bergh P, Rozing J, Nagelkerken L. Identification of two moieties of β-endorphin with opposing effects on rat T-cell proliferation. Immunology 1993; 79: 18-23.
36. Mathews PM, Froelich CJ, Sibbitt WL, Bankhurst AD. Enhancement of natural cytotoxicity by beta-endorphin. J. Immunol. 1983; 130: 1658-1662.
37. Mandler RN, Biddison WE, Mandler R, Serrate SA. β-Endorphin augments the cytolytic activity and interferon production of natural killer cells. J. Immunol. 1986; 136: 934-939.
38. Gilmore W, Weiner LP. β-Endorphin enhances interleukin-2 (Il-2) production in murine lymphocytes. J. Neuroimmunol. 1998; 18: 125-138.
39. Navolotskaya EV, Malkova NV, Zargarova TA, Lepikhova TN, Zav'yalov VP, Lipkin VM. Synthetic β-endorphin-like peptide immunorphin binds to non-opioid receptors for β-endorphin on T lymphocytes. Peptides 2001; 22: 2009-2013.